Suppr超能文献

药物和酒精成瘾中的神经激肽受体

Neurokinin receptors in drug and alcohol addiction.

作者信息

Schank Jesse R

机构信息

University of Georgia, Department of Physiology and Pharmacology, 501 DW Brooks Drive, Athens, GA 30602, USA.

出版信息

Brain Res. 2020 May 1;1734:146729. doi: 10.1016/j.brainres.2020.146729. Epub 2020 Feb 15.

Abstract

The neurokinins are a class of peptide signaling molecules that mediate a range of central and peripheral functions including pain processing, gastrointestinal function, stress responses, and anxiety. Recent data have linked these neuropeptides with drug-related behaviors. Specifically, substance P (SP) and neurokinin B (NKB), have been shown to influence responses to alcohol, cocaine, and/or opiate drugs. SP and NKB preferentially bind to the neurokinin-1 receptor (NK1R) and neurokinin-3 receptor (NK3R), respectively, but do have some affinity for all classes of neurokinin receptor at high concentrations. NK1R activity has been shown to influence reward and reinforcement for opiate drugs, stimulatory and neurochemical responses to cocaine, and escalated and stress-induced alcohol seeking. In reinstatement models of relapse-like behavior, NK1R antagonism attenuates stress-induced reinstatement for all classes of drugs tested to date. The NK3R also influences alcohol intake and behavioral/neurochemical responses to cocaine, but less research has been performed in regard to this particular receptor in preclinical models of addiction. Clinically, agents targeting these receptors have shown some promise, but have produced mixed results. Here, the preclinical findings for the NK1R and NK3R are reviewed, and discussion is provided to interpret clinical findings. Additionally, important factors to consider in regards to future clinical work are suggested.

摘要

神经激肽是一类肽信号分子,介导一系列中枢和外周功能,包括疼痛处理、胃肠功能、应激反应和焦虑。最近的数据已将这些神经肽与药物相关行为联系起来。具体而言,P物质(SP)和神经激肽B(NKB)已被证明会影响对酒精、可卡因和/或阿片类药物的反应。SP和NKB分别优先结合神经激肽-1受体(NK1R)和神经激肽-3受体(NK3R),但在高浓度时对所有类型的神经激肽受体都有一定亲和力。已表明NK1R活性会影响阿片类药物的奖赏和强化、对可卡因的刺激和神经化学反应,以及强化和应激诱导的觅酒行为。在类似复发行为的复吸模型中,NK1R拮抗作用会减弱迄今为止所测试的所有类型药物的应激诱导复吸。NK3R也会影响酒精摄入以及对可卡因的行为/神经化学反应,但在成瘾临床前模型中,针对这一特定受体的研究较少。在临床上,靶向这些受体的药物已显示出一些前景,但结果不一。在此,对NK1R和NK3R的临床前研究结果进行综述,并对临床研究结果进行解读。此外,还提出了未来临床工作中需要考虑的重要因素。

相似文献

1
Neurokinin receptors in drug and alcohol addiction.药物和酒精成瘾中的神经激肽受体
Brain Res. 2020 May 1;1734:146729. doi: 10.1016/j.brainres.2020.146729. Epub 2020 Feb 15.
2
The neurokinin-1 receptor in addictive processes.成瘾过程中的神经激肽-1受体。
J Pharmacol Exp Ther. 2014 Oct;351(1):2-8. doi: 10.1124/jpet.113.210799. Epub 2014 Jul 18.
4
Substance P and the Neurokinin-1 Receptor: The New CRF.P 物质和神经激肽-1 受体:新的 CRF。
Int Rev Neurobiol. 2017;136:151-175. doi: 10.1016/bs.irn.2017.06.008. Epub 2017 Aug 18.

引用本文的文献

3
Emerging pharmacological targets for alcohol use disorder.酒精使用障碍的新兴药理学靶点
Alcohol. 2024 Dec;121:103-114. doi: 10.1016/j.alcohol.2024.07.007. Epub 2024 Jul 26.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验